Effect of feeding regimens on circadian rhythms: Implications for aging








































I. Circadian rhythms, well-being, and life span  
 
Organisms on earth evolved to restrict their activity to 
the night or day, being nocturnal or diurnal, 
respectively. By developing an endogenous circadian 
(circa – about; dies - day) clock, which can be entrained 
to external stimuli, primarily light, animals and plants 
ensure that physiological processes are performed at the 
appropriate, optimal time of day or night [1]. Adapta-
tion to external conditions through clock entrainment 
imparts a survival advantage, as the organism can 
predict environmental changes [1-3].  The clock core 











































ternal cues, e.g., in constant darkness, the endogenous 
rhythms free-run, generating cycles of approximately 
but not exactly 24 hours.  
  
In mammals, the circadian clock influences nearly all 
aspects of physiology and behavior, such as sleep-wake 
cycles, cardiovascular activity, endocrine system, body 
temperature, renal activity, physiology of the 
gastrointestinal tract, and hepatic metabolism [1, 2]. 
Epidemiological studies indicate that myocardial 
infarction, pulmonary edema, hypertensive crises, and 
asthma and allergic rhinitis attacks, all peak at certain 
times during the day [4-6]. Disruption of circadian 























Abstract:  Increased  longevity  and  improved  health  can  be  achieved  in  mammals  by  two  feeding  regimens,  caloric
restriction (CR), which limits the amount of daily calorie intake, and intermittent fasting (IF), which allows the food to be
available  ad  libitum  every  other  day.  The  precise mechanisms mediating  these  beneficial  effects  are  still  unresolved.
Resetting the circadian clock is another intervention  that can lead to increased life span and well being, while clock




to  synchrony  in  metabolism  and  physiology.  This  hypothesis  is  reinforced  by  a  transgenic  mouse  model  showing
spontaneously reduced eating alongside robust circadian rhythms and increased life span. This review will summarize
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hormone imbalance, some aspects of disease, and 
reduced life span [2, 7-12]. For instance, psychological 
and sleep disorders [2] and cardiovascular diseases [13, 
14] can be associated with irregular or dysfunctional 
circadian clock. Disruption of circadian coordination can 
also accelerate cancer proneness and malignant growth in 
animals and humans, suggesting that the circadian clock 
controls tumor progression [8-10]. In addition, symptoms 
seen in jet lagged travelers, e.g., fatigue, disorientation, 
and insomnia, or in shift workers, e.g., altered hormone 
profiles and morbidity, result from the constant need to 
extend wakefulness or to repeatedly invert the normal 
sleep-wake cycle [10, 15, 16]. Also, chronic reversal of 
the external light-dark cycle at weekly intervals resulted 
in a significant decrease in the survival time of 
cardiomyopathic hamsters [7]. Importantly, circadian 
rhythms change with normal aging in animals and 
humans, including a shift in the phase and decrease in 
amplitude [15-18]. By using a more direct approach, it 
was shown that  longevity was diminished in golden 
hamsters carrying a 20 h-period mutation, tau, raised in 
24 h light-dark cycles [19]. On the contrary, life span was 
extended in aged animals given fetal suprachiasmatic 
implants that restore higher amplitude rhythms [19-21]. 
Altogether, it seems that circadian disruption is 
associated with multiple negative manifestations, 
whereas resetting of circadian rhythms  could lead  to 
increased longevity. These findings, although largely 
correlative, point to a critical role for the circadian clock 
in maintaining normal peripheral physiology.  
 
II. The circadian clock 
 
A. The location of the mammalian circadian clock 
In mammals, the central circadian clock is located in the 
suprachiasmatic nuclei (SCN), a distinct bilateral group 
of cells located in the anterior hypothalamus in the 
brain. Similar clock oscillators have been found in 
many peripheral tissues, such as the liver, intestine, 
heart, adipose tissue, retina and in various regions of the 
brain  [2, 22-24]. The SCN clock is composed of 
multiple, intracellular circadian oscillators, which, when 
synchronized, generate coordinated circadian outputs 
that regulate overt rhythms [25-28]. SCN oscillation is 
not exactly 24 h and it is necessary
  to entrain the 
circadian pacemaker each day to the external light-dark 
cycle to prevent drifting (or free-running) out of phase. 
Light perceived primarily by melanopsin-expressing 
retinal ganglion cells transmit signals to the SCN via the 
retinohypothalamic tract (RHT) [2, 29, 30]. As a result, 
vasoactive intestinal polypeptide (VIP), an intrinsic 
SCN factor, acutely activates and synchronizes SCN 
neurons [31, 32]. Synchronization among SCN neurons 
leads to the sending of signals to peripheral oscillators 
to prevent the dampening of circadian rhythms in these 
tissues. The SCN accomplishes this task via neuronal 
connections or circulating humoral factors [33] although 
the mechanisms are not fully understood (Figure 1). 
Several humoral factors expressed cyclically by the 
SCN, such as transforming growth factor α (TGFα) 
[34], prokineticin 2 (PK2) [35], and cardiotrophin-
like cytokine (CLC) [36], have been shown to affect 
peripheral clocks. Their intracerebroventricular 
injection inhibits nocturnal locomotor activity, an 
SCN output. Complete electrical destruction of SCN 
neurons abolishes overall circadian rhythmicity in SCN-
controlled tissues, because of the loss of synchrony 
among individual cells in the periphery and damping of 
the rhythm at the population level [37]. However, at the 
cellular level each cell oscillates, but with a different 
phase [37, 38]. The fraction of cyclically expressed 
transcripts in each peripheral tissue ranges between 5-
20% of the total population and the vast majority of 
these genes are tissue-specific [24, 39-47]. These 
findings emphasize the circadian control over a large 
portion of the transcriptomes in peripheral tissues. 
Considering the circadian gene expression in peripheral 
tissues, it is difficult to determine whether the SCN 
clock drives these rhythmic patterns directly or 
indirectly by driving rhythmic feeding, activity, and/or 
body temperature, which, in turn, contribute to rhythms 
in gene expression in the periphery. It has been shown 
that for a peripheral tissue, such as the liver, signals 
both from the SCN clock or the local endogenous clock 
may control rhythmic gene expression [48, 49].  
 
B. The biological clock at the molecular level 
Genetic analysis of mutations affecting the clock in 
Neurospora,  Drosophila, Cyanobacteria, Arabidopsis, 
and, recently, the mouse have paved the way for the 
identification of clock genes. In mammals, the clock is an 
intracellular mechanism sharing the same molecular 
components in SCN neurons and peripheral cells [3]. 
Generation of circadian rhythms is dependent on the 
concerted co-expression of specific clock genes. Trans-
criptional-translational feedback loops lie at the very 
heart of the core clock mechanism. Many clock gene 
products function as transcription factors, which possess 
PAS (PER, ARNT, SIM) and basic helix-loop-helix 
(bHLH) domains involved in protein-protein and protein-
DNA interactions, respectively. These factors ultimately 
activate or repress their own expression and, thus, 
constitute self-sustained transcriptional feedback loops. 
Changes in concentration, subcellular localization, post-
transcriptional microRNA regulation, posttranslational 
modifications (phosphorylation, acetylation, deacetyla-
tion, SUMOylation), and delays between transcription 
and translation are crucial in order to achieve a 24-h 
cycle [1, 2, 50-52].  
 
 




































In the mouse, the first clock gene identified, encodes the 
transcription factor CLOCK (Circadian Locomotor 
Output Cycles Kaput)  [53], which dimerizes with 
BMAL1 (brain and muscle ARNT-like protein 1) to 
activate transcription. CLOCK and BMAL1, two 
bHLH-PAS transcription factors, are capable of 
activating transcription upon binding to E-box (5’- 
CACGTG -3’) and E-box-like promoter sequences [2]. 
BMAL1 can also dimerize with other CLOCK 
homologs, such as neuronal PAS domain protein 2 
(NPAS2), to activate transcription and sustain 
rhythmicity [54, 55]. Amongst the regulatory targets of 
CLOCK:BMAL1 are the three Period genes (Per1, 
Per2, and Per3), which encode PAS domain factors, 
and two Cryptochrome genes (Cry1 and Cry2). PERs 
and CRYs function as negative regulators, blocking 
CLOCK:BMAL1-mediated transcriptional activation [2, 
56] (Figure 2A). Thus, CLOCK:BMAL1 heterodimers 










































large number of genes including those of the negative 
feedback loop Pers and Crys. When PERs and CRYs 
are produced in the cytoplasm, they oligomerize after 
reaching an appropriate concentration and translocate to 
the nucleus to inhibit CLOCK:BMAL1-mediated 
transcription. All the aforementioned clock genes 
exhibit a 24-h oscillation in SCN cells and peripheral 
tissues, except for Clock that has been shown not to 
oscillate in the SCN [50]. Recent studies have 
demonstrated that CLOCK has intrinsic histone 
acetyltransferase activity, suggesting that rhythmic 
activation of chromatin remodeling may underlie the 
clock transcriptional network [57, 58]. Indeed, cyclic 
histone acetylation and methylation have been observed 
on the promoters of several clock genes [58-63]. In 
addition, CLOCK also acetylates several proteins of the 
core clock apparatus, thus, enabling cycles of 
acetylation and deacetylation, the latter activity 
involving SIRT1 will be discussed below (Figure 2).  
 
 








































Several other players appear to be important to sustain 
clock function. Casein kinase I epsilon  (CKIε) 
phosphorylates the PER proteins and, thereby, enhances 
their instability and degradation [50, 64-66]. CKIε also 
phosphorylates and partially activates the transcription 
factor BMAL1 [67]. Bmal1 expression is negatively 
regulated by the transcription factor reverse erythro-
blastosis virus α (REV-ERBα) [68], which recruits 
histone deacetylase (HDAC) complexes [69]. Bmal1 
expression is positively regulated by retinoic acid 
receptor-related orphan receptor α (RORα) and RORγ 
[70]  via the ROR response element (RORE) [71]. 
Thus, Bmal1 oscillation is driven by a rhythmic change 
in RORE occupancy by RORs and REV-ERBα. This 









































Pers,  Crys,  and  other  clock‐controlled  genes.  The  negative  feedback  loop,  PERs:CRYs,  binds  to  CLOCK:BMAL1  and 









levels of REV-ERBα, a result of direct transcriptional 
activation of the Rev-erbα gene by the heterodimer 
CLOCK:BMAL1 [68]. Indeed, mice deficient in RORα 
or REV-ERBα have impaired circadian rhythms of 
locomotor activity and clock gene expression [68, 70] 
(Figure 2B). 
 
III. The biological clock and energy homeostasis 
 
A. Circadian rhythms and metabolism 
The circadian clock has been reported to regulate 
metabolism and energy homeostasis in peripheral 
tissues [72, 73]. This is achieved by mediating the 
expression and/or activity of certain metabolic enzymes 
and transport systems [74, 75]  involved in metabolic 
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nuclear receptors involved in lipid and glucose 
metabolism has been found to exhibit circadian 
expression [81]. Many hormones involved in 
metabolism, such as insulin [76], glucagon [82], 
adiponectin [83], corticosterone [84], leptin, and ghrelin 
[85, 86], have been shown to exhibit circadian 
oscillation. Leptin, an adipocyte-derived circulating 
hormone, acts at specific receptors in the hypothalamus 
to suppress appetite and increase catabolism. Leptin 
exhibits striking circadian patterns in both gene 
expression and protein secretion, with peaks during the 
sleep phase in humans [87]. Neither feeding time nor 
adrenalectomy affected the rhythmicity of leptin release. 
However, ablation of the SCN has been shown to 
eliminate leptin circadian rhythmicity in rodents, 
suggesting that the central circadian clock regulates 
leptin expression [88]. Receptors for leptin and ghrelin 
are present on SCN cells [89-91], so it is possible that 
these hormones bind directly to SCN neurons, similarly 
to their effect on the orexigenic neuropeptide Y (NPY) 
and agouti-related protein (AgRP) neurons. Indeed, 
exogenous leptin was reported to phase-advance 
rhythms of neuronal firing in rat SCN slices [92]. 
Activation of ventromedial arcuate nucleus (vmARC) 
neurons by systemic administration of the ghrelin 
mimetic growth hormone-releasing peptide 6 combined 
with SCN tracing showed that vmARC neurons transmit 
feeding-related signals to the SCN [90]. This injection 
induced Fos in the vmARC and resulted in attenuation 
of light-induced phase delay in mice and light-induced 
Fos expression in the SCN in rats [93]. Administration 
of ghrelin in vitro to SCN slices or SCN explants from 
Per2::luc  transgenic mice caused phase shifts in 
Per2::luc  reporter gene expression. However, intra-
peritoneal injection of ghrelin to wild type mice caused 
phase shifts only after 30 h of food deprivation, but not 
when the mice were fed ad libitum [94]. Thus, it seems 
that ghrelin and leptin may affect the SCN directly or 
through their effect on the ARC, which is then relayed 
to the SCN. 
 
Experiments using cultured cells have suggested that 
the cellular redox state is capable of influencing 
rhythms [95]. CLOCK and its homolog NPAS2 can 
bind efficiently to BMAL1 and consequently to E-
box sequences in the presence of reduced 
nicotinamide adenine dinucleotides (NADH and 
NADPH) (Figure 2A). On the other hand, the 
oxidized forms of the nicotinamide adenine 
dinucleotides (NAD
+ and NADP
+) inhibit DNA 
binding of CLOCK:BMAL1 or NPAS2:BMAL1 [95, 
96]. As the NAD(P)
+/NAD(P)H redox equilibrium 
depends on the metabolic state of the cell, this ratio 
could dictate the binding of CLOCK/NPAS2:BMAL1 
to E-boxes and result in phase-shifting of cyclic gene 
expression [74, 95, 96]. NAD
+ is also required for 
the activation of SIRT1, a deacetylase involved in 
clock modulation, as will be discussed below. 
 
B. The circadian clock and crucial metabolic factors 
are tightly linked 
BMAL1: Circadian clocks have been shown to be 
present in several fat tissues, including inguinal white 
adipose tissue, epididymal white adipose tissue, and 
brown adipose tissue [45, 97, 98]. Recent transcriptome 
studies revealed rhythmic expression of clock and 
adipokine genes, such as resistin, adiponectin, and 
visfatin, in visceral fat tissue [83]. Recent molecular 
studies established the involvement of BMAL1 activity 
in the control of adipogenesis and lipid metabolism in 
mature adipocytes. Embryonic fibroblasts from Bmal1
-/- 
knockout mice failed to differentiate into adipocytes. 
Loss of BMAL1 expression led to a significant decrease 
in adipogenesis and gene expression of several key 
adipogenic/lipogenic factors. Furthermore, over-
expression of BMAL1 in adipocytes increased lipid 
synthesis activity. Thus, BMAL1, a master regulator of 
circadian rhythms, plays important roles in the 
regulation of adipose differentiation and lipogenesis in 
mature adipocytes [99]. 
 
REV-ERBα: Another important candidate to link the 
circadian clock with lipid metabolism is REV-ERBα. 
This pro-adipogenic transcription factor, whose levels 
increase dramatically during adipocyte differentiation 
[100], exhibits striking diurnal variations in expression 
in murine adipose tissue [101] and rat liver [102]. 
During adipocyte differentiation, REV-ERBα acts 
downstream of the differentiation factor peroxisome 
proliferator receptor-γ (PPARγ) by facilitating gene 
expression of PPARγ target genes [103, 104]. Ectopic 
REV-ERBα expression in 3T3L1 pre-adipocytes 
promotes their differentiation into mature adipocytes 
[103]. In addition to its role in lipid metabolism and 
adipocyte differentiation, REV-ERBα is a component of 
the core clock apparatus, as mentioned above (Figure 
2B). It acts as a negative regulator of Bmal1 
expression, and its encoding gene, Rev-erbα, is 
directly activated by the CLOCK:BMAL1 heterodimer 
[68].  
 
PPARα: Peroxisome proliferator-activated receptor α 
(PPARα) is a member of the nuclear receptor family 
that plays a unique role at the intersection of circadian 
and lipid metabolic pathways. The CLOCK:BMAL 
heterodimer mediates the expression of PPARα, which 
subsequently binds to the peroxisome-proliferator 
response element (PPRE) and activates transcription of 
Bmal1  [105-107] (Figure 2B). PPARα also regulates 
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metabolism upon binding of endogenous free fatty acids 
[108, 109]. Thus the circadian rhythmicity of PPARα 
provides an example of a reciprocal link between 
circadian and lipid metabolic processes. 
 
PPARγ coactivator (PGC-1α): PGC-1α, a transcriptio-
nal co-activator that regulates energy metabolism, is 
rhythmically expressed in the liver and skeletal muscle 
of mice. PGC-1α stimulates the expression of Bmal1 
and Rev-erbα, through co-activation of the ROR family 
of orphan nuclear receptors [110, 111] (Figure 2B). 
Mice lacking PGC-1α show abnormal diurnal rhythms 
of activity, body temperature, and metabolic rate, due to 
aberrant expression of clock genes and those involved 
in energy metabolism. Analyses of PGC-1α-deficient 
fibroblasts and mice with liver-specific knockdown of 
PGC-1α indicate that it is required for cell-autonomous 
clock function [110]. 
 
AMP-activated protein kinase (AMPK): AMPK could 
be another important link that integrates the circadian 
clock with metabolism. AMPK is a sensor of the energy 
status within cells, which upon activation acts to restore 
energy balance [112, 113]. This is done in part by 
modulating NAD
+ levels and SIRT1 activity [114, 115]. 
AMPK has been found to directly phosphorylate Ser-
389 of CKIε in Rat-1 fibroblasts, resulting in increased 
CKIε activity and degradation of mPER2 (Figure 2A). 
mPER2 degradation led to a phase advance in the 
circadian expression pattern of clock genes [116]. 
AMPK has also been shown to phosphorylate and 
destabilize mCRY1 in mouse fibroblasts, leading to 
altered circadian rhythms [117] (Figure 2A). In 
addition, the expression profile of clock-related genes, 
such as Per1 and Cry2 in skeletal muscle, as well as the 
diurnal shift in energy utilization, is impaired in 
AMPKγ3 subunit knockout mice in response to 5-
amino-4-imidazole-carboxamide riboside (AICAR), an 
AMPK activator  [118]. In addition to its intracellular 
role, AMPK is involved in whole body energy 
metabolism by regulating the response to feeding in the 
hypothalamus [112].  In this brain area, AMPK 
activation is inhibited by leptin and insulin, hormones 
which suppress feeding, whereas it is activated under 
starvation by ghrelin, a hormone primarily produced by 
the stomach that leads to increased food intake  [119-
122]. 
 
SIRT1: Another protein recently found to link 
metabolism with the circadian clock is SIRT1. This is 
the mammalian ortholog of yeast Sir2, an NAD
+-
dependent histone deacetylase involved in 
transcriptional silencing and genome stability in yeast 
[123, 124]. Sir2 or its ortholog enzymes are involved in 
life span extension and the response to caloric 
restriction in yeast, Caenorhabditis elegans, Drosophila 
[123, 125], and mice  [115, 126]. The dependence on 
NAD
+ as a cofactor for catalysis is thought to link 
SIRT1 activity to the energy state of the cell [127]. 
Non-histone substrates of SIRT1, as found in C2C12 
myotubes, include regulatory molecules that modulate 
energy metabolism, such as PPARγ and PGC-1α [114], 
key factors that regulate the core molecular clock 
(Figure 2). Recent studies show  that SIRT1 interacts 
directly with CLOCK and deacetylates BMAL1 and 
PER2 in cultured fibroblasts [128, 129] (Figure 2A). It 
seems that after binding to E-box, CLOCK and 
CBP/p300 acetylate histones H3 and H4 [57] and 
BMAL1 [130]. BMAL1 acetylation potentiates its 
binding by the repressive PER/CRY complex [130] and, 
as a result, PER2 is acetylated [128]. When acetylated, 
PER2 [128] and possibly BMAL1 [129] are more 
stable. SIRT1 then becomes activated and deacetylates 
BMAL1, PER2, and histones [131]. Deacetylated PER2 
is further phosphorylated and degraded and a new cycle 
begins (Figure 2A). It has also been shown that the 
CLOCK:BMAL1 heterodimer regulates the circadian 
expression of NAMPT (nicotinamide phosphoribosyl-
transferase), a rate-limiting enzyme in the NAD
+ 
salvage pathway. SIRT1 is recruited to the Nampt 
promoter and contributes to the circadian synthesis of 
its own coenzyme [132]. Most recently, it has been 
shown that AMPK enhances SIRT1 activity by 
increasing cellular NAD
+ levels, resulting in the 
deacetylation and modulation of the activity of 
downstream SIRT1 targets [114]. Thus, the levels of 
NAD
+ together with the cycling of SIRT1 can 
determine the activity and robustness of clock gene 
transcription at least in cultured cells.  
 
C. Clock mutations and metabolic disorders 
The most compelling linkage between metabolic 
disorders and the circadian clock is demonstrated by the 
phenotypes of clock gene mutants and knockouts. 
Homozygous C57BL/6J Clock
Δ19 mice, with a truncated 
exon 18 and deleted exon 19 of the Clock gene, have a 
greatly attenuated diurnal feeding rhythm, are 
hyperphagic
  and obese, and develop a metabolic 
syndrome of hyperleptinemia,
  hyperlipidemia, hepatic 
steatosis, and hyperglycemia [133]. Loss of circadian 
rhythms in Clock
Δ19 mutant mice was accompanied by 
attenuated expression of hypothalamic peptides 
associated with energy balance, such as ghrelin and 
orexin [133]. Insulin administration caused significantly
 
greater hypoglycemia in Clock
Δ19 mutant mice than in 
wild
 type mice [134]. Increased insulin sensitivity was 
also seen in Clock
￿19 mutant mice of the BALB/c/CBA 
background that preserve rhythmicity in melatonin 
production [135]. In Clock
Δ19 on an Jcl:ICR background, 
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significantly lower than in wild type control mice, 
whereas total cholesterol and glucose, insulin, and 
leptin levels did not differ [136]. Unlike C57BL/6J 
Clock
Δ19 mutant mice, Jcl:ICR Clock
Δ19  mutant
  mice 
were not obese, had low or normal fasting plasma
 
glucose, low plasma free fatty acids, and normal plasma 
leptin. However, in Jcl:ICR Clock
Δ19 mutant mice, high 
fat diet amplified the diurnal variation in glucose 
tolerance and insulin sensitivity, and obesity was 
attenuated through impaired dietary fat absorption 
[136]. Although the effects on metabolism were 
variable due to strain differences, the overall picture is 
that disruption of the clock gene leads to disruption of 
metabolic pathways.  
 
Bmal1
-/- knockout mice, similarly to C57BL/6J 
Clock
Δ19mutant mice, exhibited suppressed diurnal 
variations in glucose and triglycerides as well as 
abolished gluconeogenesis. Liver-specific deletion of 
Bmal1 showed a direct effect of the liver clock on 
glucose metabolism, as exhibited by hypoglycemia 
during fasting, exaggerated glucose clearance, and loss 
of rhythmic expression of hepatic glucose regulatory 
genes [137]. Although recovery from insulin-induced 
hypoglycemia was impaired in C57BL/6J Clock
Δ19 
mutant and Bmal1
-/- knockout mice, the counter-
regulatory responses of corticosterone and glucagon 
were retained [134].  
 
Mutation in another central clock gene, Per2 (mPer2
-/- 
mice), exhibited no glucocorticoid rhythm even though 
the corticosterone response to hypoglycemia was intact. 
In addition, the diurnal feeding rhythm was absent in 
these mice. Although food consumption was similar 
during the light and dark periods on high fat diet, 
mPer2
-/- mice developed significant obesity [138]. 
 
IV. Effect of feeding regimens on circadian rhythms 
 
In addition to light, feeding regimens have been 
reported to affect the clocks in the SCN and/or the 
periphery. 
 
A. Restricted feeding (RF) 
RF limits the time and duration of food availability with 
no calorie reduction [3, 74, 139].  Animals, which 
receive food ad libitum everyday at the same time for 
only a few hours, adjust to the feeding period within a 
few days [49] and can consume their daily food intake 
during that limited time [140, 141]. Restricting food to a 
particular time of day has profound effects on the 
behavior and physiology of animals. Many physio-
logical activities that are normally dictated by the 
master clock in the SCN are altered by RF, such as 
hepatic P450 activity, body temperature, locomotor 
activity, and heart rate [142-145]. 2-4 h before the meal, 
the animals display food anticipatory activity (FAA), 
which is typified
 by an increase in locomotor activity, 
body temperature, corticosterone secretion,
  gastro-
intestinal motility, and activity of digestive enzymes 
[140, 146-148], all are known output systems of the 
biological clock. RF is dominant over the SCN and 
drives rhythms in arrhythmic and clock mutant mice 
and animals with lesioned SCN, regardless of the 
lighting conditions [142,  143, 148-151]. In most 
incidents, RF affects the core clock apparatus in 
peripheral tissues, such as liver (Figure  3), kidney, 
heart, and pancreas, with no effect on the central 
pacemaker in the SCN  [3, 74, 139, 143, 150, 152, 153], 
causing uncoupling from the central pacemaker in the 
SCN. This suggests that nutritional regulation of clock 
oscillators in peripheral tissues may play a direct role in 
coordinating metabolic oscillations [154]. As soon as 
food availability returns to normal, the SCN clock, 
whose
 phase remains unaffected,
 resets the peripheral 
oscillators [152]. The location of this food-entrainable 
oscillator (FEO) has been elusive. Lesions in the 
dorsomedial hypothalamic nucleus (DMH) [155-158], 
the brain stem parabrachial nuclei (PBN) [156, 159], 
and the core and shell regions of nucleus accumbens 
[160, 161] revealed that these brain regions may be 
involved in FEO output, but they cannot fully account 
for the oscillation [162]. Neither vagal signals nor leptin 
are critical for the entrainment [163, 164].  CLOCK 
[165] or BMAL1 [166] and other clock genes [167] 
have been shown not to be necessary for food 
anticipatory activity. However, it has recently been 
demonstrated that mPer2 mutant mice did not exhibit 
wheel-running food anticipation [168, 169]. Recently, 
the FEO was suggested to be localized, in part, in 
ghrelin-secreting cells in the stomach [170]. Clearly, the 
localization and nature of the FEO and the effect of RF 
on circadian rhythms warrants further study.  
 
The effect of RF on ageing and longevity has never 
been studied. Interestingly, the survival of Glasgow 
osteosarcoma-inoculated mice was prolonged under an 
RF regimen during the light period compared to those 
under the dark period or those fed ad libitum [171]. 
Also, RF modified the expression of genes involved in 
carcinogenesis and tumor progression, such as c-myc 
and p53 [172]. It remains to be determined whether RF 
feeding affects life span. 
 
B. Calorie restriction (CR) 
CR, sometimes denoted dietary restriction (DR), refers 
to a dietary regimen low in calories without mal-
nutrition, that restricts the daily amount of calories 
derived from carbohydrates,  fats,  or proteins usually to  
 
 















































60-75% of ad libitum-fed animals. CR extends the life 
span of diverse species, such as C. elegans, 
Drososphila, rodents  [125, 173, 174], and recently 
monkeys [175]. CR in mice, rats, and monkeys prevents 
or delays the onset of major age-related diseases, such 
as cancer, diabetes, kidney disease, and cataracts [173, 
176]. In humans, long-termed CR results in sustained 
beneficial effects on major risk factors for athero-
sclerosis, type 2 diabetes, and inflammation [177]. The 
reduction of energy intake is considered to be the 
critical beneficial factor in the CR regimen [173]. 
Theories on how CR modulates aging and longevity 
abound, but the exact mechanism is still unclear [178]. 
For a long  time, the most prevalent explanation was 
related to the widely acceptable theory on aging, the 
Free Radical Theory. This theory attributes the aging 
process to the continuous  accumulation of oxidative 
damage in macromolecules generated by reactive 
oxygen species (ROS) produced in the mitochondria 
[179]. A later variation of this theory, the  Oxidative 
Stress Theory, attributes the oxidative damage to the 
imbalance between preoxidant and antioxidant 
components, and CR was suggested to increase the 
resistance to oxidative stress [180]. Recently, this 
explanation was put into question, at least for rodents, 
as increasing oxidative stress by several genetic 
alterations increased aging-related diseases, such as 
cancer, but did not diminish life span [181-183]. ROS, 
primarily H2O2, have recently been suggested to 
promote aging as activators of the TOR (target of 
rapamycin) pathway [184]. This signaling pathway acts 
as a sensor of the nutritional and energetic state in the 
cell and transmits anabolic signals to regulate cell size, 
growth, and metabolism. Mammalian TOR (mTOR) 
could play an important role in the regulation of life 
span, as indicated by findings showing that CR 
attenuated mTOR signaling in several tissues in mice 
[185], and mice deficient of ribosomal protein S61 
kinase 1, a central component in mTOR signaling, or 
mice treated with rapamycin, an inhibitor of the 
mTORC1 component, exhibited increased life span 
[186, 187]. Interestingly, mTOR has also been recently 
linked to the circadian clock as a light-activated 





extracted  from  liver  tissue  collected  every  3  h  around  the 
circadian cycle (mean ± SEM; n=3 for each time‐point and each 
mouse  group)  was  reverse  transcribed  and  analyzed  by 
quantitative real time PCR. Clock gene levels were normalized 
using  Gapdh  as  the  reference  gene.  The  grey  and  black  bars 
designate the subjective light and dark cycles, respectively.  
 
CR-fed animals resemble RF-treated animals, as they 
usually consume all or most of their food within a short 
period of time. While anticipating for food, calorically 
restricted animals show a rise in body temperature 
[189]. Thus, due to the temporal component of food 
intake, it is possible that CR, similarly to RF, 
synchronizes peripheral clocks and influences clock-
controlled output systems, such as the anticipatory 
behavior and body temperature. As opposed to RF, CR 
entrains the clock in the SCN [190-192]. Under light-
dark conditions and daytime feeding, calorically 
restricted mice showed strong FAA but with a phase 
advance of the nocturnal pattern of activity, a direct 
output of the SCN clock. When mice were transferred to 
dark-dark conditions, i.e. under free-running conditions, 
and fed ad libitum, the onset of the nocturnal period of 
locomotor activity occurred significantly earlier (1.3 h) 
in the calorically restricted than in ad libitum-fed 
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did not differ between calorically restricted and ad 
libitum-fed mice [190]. Also, when SCN clock gene 
expression was tested, slight changes in gene expression 
were observed [191, 192]. Overall, these results suggest 
that CR during the daytime affects the temporal 
organization of the SCN clockwork and circadian 
outputs in mice under light-dark cycle. In addition, CR 
affects photic responses of the circadian system, as 
measured by light pulses, suggesting that energy 
metabolism modulates gating of photic inputs in 
mammals [192]. It is noteworthy that microarray data 
comparing gene expression in seven different tissues 
under CR identified circadian rhythms among the three 
most over-expressed biological processes, with Per2 
being the most up-regulated gene [193]. Collectively, 
these findings suggest that synchronization of peripheral 
oscillators during CR could be achieved directly due to 
the temporal feeding, as has been reported for RF [143, 
152, 153], or by synchronizing the SCN [190-192], 
which, in turn, sends humoral or neuronal signals to 
entrain the peripheral tissues [194, 195]. It is not known 
whether there is dominancy or harmony between the 
central pacemaker and peripheral oscillators under CR. 
 
C. Intermittent fasting (IF) 
During IF, also denoted alternate day fasting (ADF), 
food is available ad libitum every other day. IF-treated 
mice eat on the day they have access to food 
approximately twice as much as those having 
continuous access to food [196-198]. Similarly to 
calorically restricted animals, IF-fed animals exhibit 
increased life span in comparison with the ad libitum-
fed control, even if there is little or no overall decrease 
in calories [199, 200].  IF-fed animals also exhibit 
improved glucose metabolism, cardio-protection, neuro-
protection [196, 201-205], and increased resistance to 
cancer  [197, 200]. IF may also decrease the risk for 
cardiovascular diseases in humans [206].  The IF-
induced beneficial effects are thought to occur 
independently of the overall caloric intake, but the 
underlying mechanisms are still unknown. One 
suggested mechanism is stimulation of cellular stress 
pathways induced by the IF regimen [196, 207, 208]. 
Brain-derived neurotrophic factor (BDNF), normally 
involved in brain development and plasticity, is elevated 
in IF animals, and is causally linked to the protective 
effect of the IF regimen against neuronal damage 
inflicted by the neurotoxin kainic acid [209]. It must be 
noted, however, that BDNF could not be linked to the 
neuro-protective effects in the brain of calorically 
restricted rats [210, 211], but increased levels of another 
neurotrophic factor, glial cell line-derived factor 
(GDNF), were correlated with neuro-protection of a 
calorically restricted primate model of Parkinson’s 
disease [212]. Interestingly, BDNF is also a component 
of the hypothalamic melanocortin pathway that controls 
food intake and body weight in adult mice [213], and it 
has been implicated in the regulation of energy 
metabolism [214].  Heterozygous  knockout BDNF 
(BDNF
+/-) mice exhibit metabolic abnormalities, 
hyperphagia, obesity, and insulin resistance that could 
be significantly reversed by IF, indicating that BDNF is 
indeed involved in the beneficial effects induced by IF 
[214].  Interestingly,  the  BDNF
+/- mice resemble 
circadian  Clock mutant mice [133] in metabolic 
abnormalities. In addition, BDNF and its cognate 
receptor TrkB were suggested to play a role in circadian 
modulation of the SCN pacemaker sensitivity to light 
[215, 216]. These data point to the possibility that IF 
could affect the SCN and, as a result, peripheral clocks, 
at least via elevating BDNF levels. 
 
Recently, we have shown that, under an IF protocol, 
when food was introduced during the light period, mice 
exhibited almost arrhythmicity in clock gene expression 
in the liver. Unlike daytime feeding, nighttime feeding 
yielded rhythms similar to those generated during ad 
libitum feeding [198] (Figure 3). Furthermore, rhythms 
were maintained when daytime IF occurred under 
disruptive light, suggesting that SCN signals were 
involved in inducing the arrhythmic state in the periphery 
[198]. Thus, the fact that IF can affect circadian rhythms 
differently depending on the timing of food availability 
and light conditions suggests that this regimen affects the 
SCN clock, similarly to CR. We assume that SCN 
resetting by IF and CR could be involved in the health 
benefits conferred by these regimens [195].  
 
The effects of IF are in contrast to those of restricted 
feeding (RF) that dictates peripheral rhythms in 
arrhythmic and mutant mice and animals with lesioned 
SCN regardless of the lighting conditions [142, 143, 
148-151] (Figure 3). It, thus, appears that IF is not as 
dominant as RF in dictating peripheral rhythms. Never-
theless, this feeding regimen exhibits some similarities 
with RF, as reflected by the anticipatory feeding 
behavior that preceded food availability and restoration 
of circadian rhythms under disruptive light conditions, 
due most likely to the effect on the food entrainable 
oscillator (FEO) [198]. Thus, under daytime IF, clock 
gene expression in the periphery would be controlled by 
the SCN, which responds to both light-dark cycle and 
IF, as well as directly by the temporal feeding via the 
FEO. Co-activation of both the FEO and the SCN 
would yield rhythms at two opposite phases leading to 
overall arrhythmicity. In contrast, under nighttime IF, 
normal rhythms are generated, as both the FEO and the 
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or IF-induced increased longevity 
 
A. Long-lived, spontaneously calorically restricted 
αMUPA mice 
αMUPA mice carry as a transgene, the urokinase-type 
plasminogen activator (uPA), an extracellular fibrinolytic 
serine protease implicated in tissue remodelling [218] 
and brain development and plasticity [219-224]. αMUPA 
mice spontaneously eat less (20-30%) compared to their 
wild type (WT) FVB/N control mice when fed ad 
libitum, indicating that their appetite is genetically 
suppressed. The mechanism linking transgenic uPA to 
reduced hunger is not yet clear. It could be related to uPA 
over-expression in the brain stem, as was found in two 
transgenic lines showing reduced food intake [225]. The 
transgenic effect is likely to be developmental, similarly 
to the remodelling effect recently detected in αMUPA 
developing incisor teeth [226]. αMUPA mice live longer 
(median, 16%; 10
th decile, 15%) than WT mice [227], 
thus resembling calorically restricted animals in showing 
an inverse relation between  food intake and life span. 
αMUPA mice exhibit additional similarities with 
calorically restricted mice, such as reduced body weight, 
reduced levels of serum IGF-1 or glucose, enhanced 
capacity to conduct apoptosis, and reduced incidence of 
tumors [225, 227-230]. 
 
B. αMUPA mice, circadian rhythms, and aging  
Recent data show that αMUPA mice exhibit higher 
amplitude in the circadian expression of several clock 
























change coincides with higher amplitude rhythms of 
food intake and body temperature [194]. Since circadian 
patterns of food intake and body temperature constitute 
clock-controlled output systems, it is conceivable that 
their alteration in the transgenic mice stems from the 
higher amplitude of clock gene expression in the 
periphery, and possibly also in the central biological 
clock in the SCN. Higher amplitude of circadian 
rhythms have been previously associated with young 
age [15]  and extended life span [19]. Support for a 
linkage between circadian rhythms and attenuation of 
aging in αMUPA mice is provided by comparing young 
vs. old mice. When tested for circadian food intake, an 
SCN output system, 18-month-old WT control mice 
exhibit a 4-6-h shift in circadian food intake compared 
to 5-month-old mice [195]. This behaviour is consistent 
with literature data showing that aging can alter the 
amplitude and/or phase of circadian rhythms [15, 16, 
18]. In contrast to WT mice, adult and young αMUPA 
mice show similar circadian food intake, indicating that 
at least some aspects of circadian behavior maintain a 
youthful pattern at an old age in these mice. At an old 
age,  αMUPA mice maintain a young and healthier 
appearance, they look lean, and their fur is shiny, 
whereas WT mice are sluggish and they look old 
(Figure 4). In addition, αMUPA mice do not become 
obese throughout their life-time, whereas about one 
third of the WT mice show severe obesity (Figure 4). 
The major difference in body weight between αMUPA 
and WT mice stems from the fact that the quantitative 
difference in food intake between αMUPA and WT 
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circadian rhythms  
It is difficult to eliminate the effect of temporal food 
consumption in calorically restricted animals, as mice 
consume their food within a few hours. αMUPA mice 
spontaneously consume reduced calories (20-30% 
reduction) compared with WT mice under different 
feeding regimens, i.e. AL, RF and IF, suggesting that 
these mice can be utilized as a model for CR in the 
absence of the imposed temporal food consumption 












































poral CR under RF or IF conditions. Therefore, the 
transgenic mouse model αMUPA [225] has recently 
been used to investigate the contribution of calorie 
reduction per se vs. timed feeding to clock adaptation 
[49]. Under light-dark conditions and ad libitum 
feeding,  αMUPA mice show high amplitude, 
appropriately reset circadian rhythms in peripheral 
clock genes [194] (Figure 5). This finding could reflect 
the effect of the reduced calorie intake on the SCN in 
αMUPA mice, as has been previously reported for 
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expression phase of all clock genes in the liver in a 
similar manner in both WT mice and αMUPA mice, and 
in some cases increased the amplitude [49] (Figure 5). 
These findings were in concert with previous results  in 
the literature, as is mentioned above. Nevertheless, an 
effect of the SCN on clock-controlled output systems 
under RF could be seen when the phases of peripheral 
clock gene expression in WT mice vs. αMUPA mice 
were compared under arrhythmicity imposed by 
disruptive light. Whereas the pattern of clock gene 
expression did not change in WT mice, a phase shift 
was seen in several genes in αMUPA mice (Figure 5), 
suggesting an SCN effect. Again, this effect of the SCN 
could be attributed to the reduced calorie intake of 
αMUPA mice. Altogether, these findings suggest that 
both the reduced calories and the light-dark cycle work 
in synchrony on the central biological clock of αMUPA 
mice to generate rhythms in the periphery. However, it 
seems that in WT mice, as has been found for other 
mouse strains, RF is dominant over the SCN in dictating 
rhythms in the periphery regardless of the lighting 
conditions. In αMUPA mice, RF dictates the phase of 
clock gene expression under light-dark; but under 
disruptive light conditions, as the SCN is under the 
influence of calorie restriction, it becomes dominant in 
dictating the phase of clock gene expression. 
 
Unlike RF, the effect of IF on circadian rhythms in 
αMUPA mice was similar to that of WT mice under 
light-dark or disruptive light conditions, and it 
resembled also that on C57BL mice (Figure 3, Figure 
5). Thus, in all mice tested, daytime IF caused 
arrhythmia in clock gene expression in the liver under 
light-dark, whereas rhythmicity was restored under 
disruptive light [198] (Figure 3). These observations 
suggest that IF, similarly to CR, may affect the SCN 
clock. This effect could possibly be mediated through a 
metabolic state generated by the day of fast during IF 
regardless of the calories consumed, as discussed 
earlier.  
 
Altogether, the findings in αMUPA mice suggest that 
reduced calories affect the SCN so it becomes dominant 
over RF in the periphery only under disruptive light 
conditions. In addition, IF affects peripheral rhythms 
depending on the timing of food availability and light 
conditions, but regardless of the total daily calorie 
consumption, suggesting that this regimen induces a 
metabolic state that affects the SCN.  
 
D. Temporal vs. quantitative food consumption and 
circadian rhythms 
Previous publications have dealt with the issue of timed 
feeding and life span, reporting that calorically 
restricted mice showed increased longevity whether fed 
twice a day at daytime, once a day at daytime or 
nighttime, several times a day at nighttime [231, 232], 
or three meals a week [233]. In these studies, the low-
calorie feeding was practically timed and confined to 
the day or night, similarly to MUPA, or introduced in 
large intervals and continued throughout life time 
allowing appropriate adaptation. As a result, timed 
feeding was suggested to lead to high amplitude 
circadian rhythms and increased life span [232, 234]. 
However, others rejected  any contribution of timed 
feeding to CR-induced longevity [174, 231]. The 
uncoupling of timed meals from reduced calories could 
practically be achieved only with animals, such as 
αMUPA, that spontaneously eat less. The results 
obtained with αMUPA indicate that temporal and 
quantitative aspects of food intake can be separately 
controlled. The timing of food intake is controlled by 
the central biological clock, whereas a separate 
mechanism appears to dictate the amount of food or 
calorie intake, that, in turn, could entrain the SCN 
clock, as has experimentally been shown for calorically 
restricted animals [191, 192]. The results achieved with 
IF suggest that IF can be beneficial when food is given 
during the activity period of the animal, as explained 
above. Indeed, neuro- and cardio-protection alongside 
increased fatty acid oxidation and improved stress 
resistance have been induced after weeks of IF 
treatment when food was introduced at the beginning of 
the activity period [205, 235-237]. It is noteworthy that 
cardio- and neuro-protection and life span extension 
were also seen when food was introduced during the 
day, but after many months of IF treatment [196, 199], 
so that the animals could adjust after such a prolonged 
treatment. In light of these findings, we assume that the 
effect of IF on the SCN through a metabolic change, as 
mentioned above, alongside the timed feeding might 
affect the SCN to yield better-reset rhythms.  
 
E. Differences between αMUPA mice and calorically 
restricted rodents 
Although αMUPA mice exhibit reduced calorie intake 
and body fat, they show remarkable differences in 
energy metabolism compared with CR-treated animals. 
In particular, calorically restricted animals exhibit high 
levels of ghrelin [238, 239], but low levels of leptin 
[240, 241] and insulin [173], indicating an overall state 
of hunger. It is noteworthy that leptin-deficient animals 
are long-lived under CR feeding regimen, suggesting 
that leptin is not necessary for the CR-mediated benefits 
[242, 243]. In addition, CR-treated mice exhibit high 
expression levels of PGC-1α and no change in PPARγ 
levels in the liver [244, 245]. All these findings are in 
sharp contrast with those found in αMUPA mice that 
have low levels of ghrelin and high levels of leptin and 
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their metabolism is of satiated rather than hungry 
animals (unpublished data). Nevertheless, one aspect 
found to be common to both αMUPA mice and 
calorically restricted animals are the low SIRT1 
expression levels in the liver [246] and high levels in 
the brain [247].  It is noteworthy that the information 
regarding SIRT1 levels in the hypothalamus of 
calorically restricted animals is still lacking, and data 
for peripheral tissues is sometimes contradictory [124, 
246]. Results obtained with SIRT1-null mice  have 
recently suggested that this enzyme could be required 
for the in vivo response to CR [248],  and transgenic 
mice over-expressing SIRT1 show a phenotype 
resembling calorically restricted animals  [249]. We 
assume that, in calorically restricted mice, SIRT1 
activity could be elevated in the brain, possibly in the 
hypothalamus and SCN, through AMPK activation, as 
AMPK can be activated in the hypothalamus under 
starvation conditions and high ghrelin  [112, 121]. In 
αMUPA mice, that show low AMPK levels in the 
hypothalamus, the high leptin levels could lead to 
SIRT1 elevation, as leptin is required for the increase in 
SIRT1 protein levels in the hypothalamus under 
starvation [250]. Thus, although stimulated through 
different pathways in αMUPA and calorically restricted 
mice, SIRT1 could act as a common factor modulating 
the SCN clock and, as a result, longevity.  
 
αMUPA mice share also some similarities with those of 
























However, there are some fundamental differences in 
Lou/C rats compared with αMUPA mice, such as   
increased levels of PGC-1α and SIRT1 in the liver, 
increased levels of ghrelin, and reduced levels of leptin 
and insulin in the serum, although with some improved 
sensitivity for the latter two hormones [251, 252]. 
Overall, it seems that αMUPA mice are metabolically 
different from Lou/C rats. 
 
F. Role of circadian rhythms in CR on health and 
longevity 
The capacity of CR to reset the SCN clock, as 
previously reported [191, 192],  and  the pronounced 
circadian rhythms seen in the long-lived αMUPA mice, 
pose the biological clock as a possible major factor 
determining longevity of calorically restricted mice 
[194, 195]. The beneficial effect induced by CR on 
health and longevity can be achieved by appropriately 
resetting and synchronising a variety of hormonal, 
biochemical, and physiological functions. In turn, some 
of these functions can feedback to the biological clock 
in the periphery [143, 153] and the SCN [191, 192] and 
help sustain the rhythms. Indeed, the redox state affects 
the dimerization of the two clock proteins CLOCK and 
BMAL1 in vitro [96]. As SIRT1 has been linked to life 
span and suggested to mediate CR-induced effects [115, 
126, 253], it could be a candidate that modulates the 
clock of calorically restricted animals, as discussed 
above. Clock resetting could lead to robust circadian 
rhythms that are associated with young ages and 
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RF entrains peripheral clocks due to temporal food 
consumption, whereas CR and IF appear to synchronize 
the central pacemaker in the SCN, suggesting a role for 
a metabolic  state imposed by low calories in central 
clock entrainment. In αMUPA mice, reduced calories 
alone were found not to be sufficient to sustain rhythms, 
unless feeding was spontaneously timed at night, or 
timed at day through a restricted feeding protocol. 
Therefore, it appears that when reduced calories are 
timed, as always occurs during CR and IF regimens, 
clock adjustment can influence a wide variety of output 
systems, so that cellular and physiological systems 
perform in a more synchronised and appropriately reset 
manner. We assume that SIRT1 could be a key mediator 
in clock synchronization at least under CR. Robust 
circadian rhythms can ensure a better tissue and body 
homeostasis, and could constitute an important mediator 
in aging attenuation and longevity extension (Figure 6). 
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